Scribe Therapeutics

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

About

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR. The company’s first technology, called X-Editing (XE) molecules, are highly engineered CRISPR enzymes that provide combined aspects of greater efficacy, specificity, and deliverability than currently available CRISPR genome editing technology. It also a long-term, engineering approach that can help establish CRISPR-based therapies as a new standard of clinical care and expand access to groundbreaking treatments that will impact millions of lives. Scribe Therapeutics is overcoming the limitations of current genome editing technologies by developing custom-engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company built for exceptional specificity within the genome – enabling therapeutic precision and allele-specific targeting. Scribe Therapeutics was founded in 2018 and is headquartered in Alameda, CA, USA.

Mission

Scribe Therapeutics is dedicated to revolutionizing the field of genetic medicine by developing advanced CRISPR-based therapies for a wide range of diseases. Their core mission is to harness the power of cutting-edge genome editing technologies to create life-changing treatments for patients in need. By fostering a culture of innovation, collaboration, and scientific excellence, Scribe Therapeutics aims to make a lasting impact on global healthcare and improve the lives of countless individuals.

Employee Benefits

  • Salary commensurate with experience
  • Intellectually stimulating, collegial, and fast-paced work environment
  • Opportunity to engineer the future of therapeutics
  • Commitment to creating a diverse environment
  • Equal opportunity employer
  • Consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, disability, age, or veteran status

Core Values

  • Innovation: Scribe Therapeutics is dedicated to pushing the boundaries of gene editing technology through innovative research and development.
  • Collaboration: Collaboration is key at Scribe Therapeutics, where teams work together to solve complex problems and achieve shared goals.
  • Integrity: Scribe Therapeutics values integrity above all else, ensuring that all research and business practices are conducted with honesty and transparency.
  • Diversity and Inclusion: Scribe Therapeutics is committed to fostering a diverse and inclusive workplace, where all employees feel valued and supported.
  • Impact: Scribe Therapeutics strives to make a positive impact on the world through its groundbreaking gene editing technology and dedication to improving human health.

Scribe Therapeutics

Leadership

Co-Founder at Scribe Therapeutics

David F. Savage

Co-Founder
CFO at Scribe Therapeutics

David Parrot

CFO
Co-Founder and VP of Platform at Scribe Therapeutics

Brett Staahl

Co-Founder and VP of Platform

Open Jobs

No items found.
Location
Alameda, CA
N/A
Company Size
11-50
N/A
Revenue Range
$1M to $10M
N/A
Valuation
N/A
Founded
2017-01-01
N/A
Current Status
Operating
N/A
Work Mode
Open Roles
8
Hiring Now
Hiring now

Funding

Total Funding
$
120000000
Funding Rounds
2
Num Investors
4
Work Mode
IPO Status
Private
Funding Stage
Early Stage Venture
Last Funding Date
2021-03-31
Last Funding Type
Series B
Hiring Now
Hiring now
Track & Research Scribe Therapeutics for Your Next Interview
Start Tracking for Free

Want Jobs in Your Inbox?

Sign up for the Teal newsletter and get career guidance and new jobs weekly!
Thank you! Your submission has been received!
Oops! Please provide a correct email address